Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDT 067 PK Bridge Study in Onychomycosis
NCT01790165Phase 2Completed
- Sponsor
- Celtic Pharma
- Start
- Dec 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules, Lipid-based Nanoparticles
01
Overview
A Phase 2 trial of TDT-067 in onychomycosis, sponsored by Celtic Pharma. Started Dec 2009; status: completed.
02
Drugs
TDT-067
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT01790165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01790165.